##gff-version 3
##sequence-region Q8NE79 1 360
Q8NE79	UniProtKB	Chain	1	360	.	.	.	ID=PRO_0000046791;Note=Blood vessel epicardial substance	
Q8NE79	UniProtKB	Topological domain	1	48	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NE79	UniProtKB	Transmembrane	49	69	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NE79	UniProtKB	Topological domain	70	70	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NE79	UniProtKB	Transmembrane	71	91	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NE79	UniProtKB	Topological domain	92	92	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NE79	UniProtKB	Transmembrane	93	113	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NE79	UniProtKB	Topological domain	114	360	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NE79	UniProtKB	Region	93	115	.	.	.	Note=Required for interaction with CAV3;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9ES83	
Q8NE79	UniProtKB	Region	136	186	.	.	.	Note=Required for interaction with KCNK2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26642364;Dbxref=PMID:26642364	
Q8NE79	UniProtKB	Modified residue	295	295	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9ES83	
Q8NE79	UniProtKB	Modified residue	318	318	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q3BCU4	
Q8NE79	UniProtKB	Glycosylation	2	2	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NE79	UniProtKB	Glycosylation	30	30	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NE79	UniProtKB	Natural variant	127	127	.	.	.	ID=VAR_053600;Note=M->I;Dbxref=dbSNP:rs9486039	
Q8NE79	UniProtKB	Natural variant	129	129	.	.	.	ID=VAR_017155;Note=R->W;Dbxref=dbSNP:rs2275289	
Q8NE79	UniProtKB	Natural variant	201	201	.	.	.	ID=VAR_075625;Note=In CARICK%3B reduces membrane localization of BVES and POPDC2%3B decreases by 50%25 affinity for cAMP%3B disrupts enhancement of KCKN2 surface expression%3B increases KCKN2 outward currents%3B no effect on total protein levels. S->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26642364;Dbxref=dbSNP:rs869025337,PMID:26642364	
Q8NE79	UniProtKB	Sequence conflict	27	27	.	.	.	Note=V->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8NE79	UniProtKB	Sequence conflict	110	110	.	.	.	Note=Y->I;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8NE79	UniProtKB	Sequence conflict	123	123	.	.	.	Note=E->D;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8NE79	UniProtKB	Sequence conflict	128	128	.	.	.	Note=Y->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8NE79	UniProtKB	Sequence conflict	132	132	.	.	.	Note=F->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8NE79	UniProtKB	Sequence conflict	342	342	.	.	.	Note=D->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8NE79	UniProtKB	Sequence conflict	358	358	.	.	.	Note=Q->R;Ontology_term=ECO:0000305;evidence=ECO:0000305	
